David J Moore
Overview
Explore the profile of David J Moore including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
411
Citations
7445
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
21.
Kapos F, Craig K, Anderson S, Bernardes S, Hirsh A, Karos K, et al.
J Pain
. 2024 Jun;
25(10):104608.
PMID: 38897311
Despite wide endorsement of a biopsychosocial framework for pain, social aspects of pain remain rarely addressed in the context of pain prevention and management. In this review, we aim to ...
22.
Ament S, Campbell R, Lobo M, Receveur J, Agrawal K, Borjabad A, et al.
Mol Psychiatry
. 2024 Jun;
29(12):3950-3961.
PMID: 38879719
Substance use disorders (SUD) and drug addiction are major threats to public health, impacting not only the millions of individuals struggling with SUD, but also surrounding families and communities. One...
23.
Wang J, Nirantharakumar K, Sainsbury C, Moore D, Sinclair A, Neil Thomas G, et al.
Syst Rev
. 2024 Jun;
13(1):155.
PMID: 38872216
Background: Due to increasing life expectancy, almost half of people with type 2 diabetes are aged 65 years or over worldwide. When metformin alone does not control blood sugar, the...
24.
Jiang X, Dahmani S, Bronshteyn M, Yang F, Ryan J, Gallagher Jr R, et al.
PLoS One
. 2024 Jun;
19(6):e0305368.
PMID: 38843217
[This corrects the article DOI: 10.1371/journal.pone.0269491.].
25.
Ellis R, Pal S, Achim C, Sundermann E, Moore D, Soontornniyomkij V, et al.
J Neuroimmune Pharmacol
. 2024 Jun;
19(1):27.
PMID: 38829507
Reverse transcriptase inhibitors (RTIs) are currently broadly prescribed for the treatment of HIV infection but are also thought to prevent Alzheimer's disease (AD) progression by protecting against amyloidosis. Our study...
26.
The impact of intimate partner violence on PrEP adherence among U.S. Cisgender women at risk for HIV
Anderson K, Blumenthal J, Jain S, Sun X, Amico K, Landovitz R, et al.
BMC Public Health
. 2024 May;
24(1):1461.
PMID: 38822300
Background: Cisgender women account for 1 in 5 new HIV infections in the United States, yet remain under-engaged in HIV prevention. Women experiencing violence face risk for HIV due to...
27.
Dretzke J, Lorenc A, Adriano A, Herd C, Mehanna H, Nankivell P, et al.
Cancer Med
. 2024 May;
12(15):16531-16547.
PMID: 38771977
Background: Current follow-up models in cancer are seen to be unsustainable and inflexible, and there is growing interest in alternative models, such as patient-initiated follow-up (PIFU). It is therefore important...
28.
Browne S, Umlauf A, Moore D, Benson C, Vaida F
JMIR Mhealth Uhealth
. 2024 May;
12:e53596.
PMID: 38722201
Background: A digital health technology's success or failure depends on how it is received by users. Objectives: We conducted a user experience (UX) evaluation among persons who used the Food...
29.
Antony Sheron V, Surenthirakumaran R, Gooden T, Lip G, Neil Thomas G, Moore D, et al.
PLoS One
. 2024 May;
19(5):e0301729.
PMID: 38718097
Background: Atrial fibrillation (AF) is the most prevalent cardiac arrhythmia in the world. AF increases the risk of stroke 5-fold, though the risk can be reduced with appropriate treatment. Therefore,...
30.
Marquine M, Kamalyan L, Zlatar Z, Yassai-Gonzalez D, Perez-Tejada A, Umlauf A, et al.
AIDS Patient Care STDS
. 2024 Apr;
38(5):195-205.
PMID: 38662469
Neurocognitive impairment and metabolic syndrome (MetS) are prevalent in persons with HIV (PWH). We examined disparities in HIV-associated neurocognitive function between Hispanic and non-Hispanic White older PWH, and the role...